Papillary Urothelial Neoplasm of Low Malignant Potential

Evolving Terminology and Concepts

Timothy D. Jones, Liang Cheng

Research output: Contribution to journalArticle

61 Citations (Scopus)

Abstract

Purpose: The most controversial aspect of the new WHO 2004/ISUP classification system is the creation of the PUNLMP diagnostic category. We discuss PUNLMP tumors and the WHO 2004/ISUP classification system with an emphasis on tumor morphology and heterogeneity, recurrence and progression rates, tumor genetics, interobserver variability and the usefulness of biomarkers and molecular diagnostic techniques for grading bladder tumors. Materials and Methods: A literature search using PubMed was performed. All relevant literature concerning PUNLMP and the WHO 2004/ISUP grading system for urothelial neoplasms was reviewed. Results: The new WHO 2004/ISUP classification reflects work in progress. Low malignant potential terminology may not reflect the true biological behavior of these tumors. Additionally, interobserver variability in making a diagnosis of PUNLMP is high despite detailed histological criteria. Urine cytopathology in the context of the WHO 2004/ISUP classification does not appear to effectively discriminate PUNLMP from low grade carcinoma. Conclusions: For practical purposes patients with PUNLMP should be treated similarly to patients with low grade, noninvasive urothelial carcinoma. It is our hope that recent advances in the molecular grading of these tumors may eventually supplant traditional morphological classification, allowing a more precise and objective assessment of the biological potential of these tumors.

Original languageEnglish
Pages (from-to)1995-2003
Number of pages9
JournalJournal of Urology
Volume175
Issue number6
DOIs
StatePublished - Jun 2006

Fingerprint

Terminology
Neoplasms
Observer Variation
Hope
Molecular Diagnostic Techniques
Carcinoma
Neoplasm Grading
PubMed
Urinary Bladder Neoplasms
Biomarkers
Urine
Recurrence

Keywords

  • bladder
  • bladder neoplasms
  • carcinoma
  • classification
  • papillary
  • urothelium

ASJC Scopus subject areas

  • Urology

Cite this

Papillary Urothelial Neoplasm of Low Malignant Potential : Evolving Terminology and Concepts. / Jones, Timothy D.; Cheng, Liang.

In: Journal of Urology, Vol. 175, No. 6, 06.2006, p. 1995-2003.

Research output: Contribution to journalArticle

@article{4fb438891b4241babecff5c189a386c2,
title = "Papillary Urothelial Neoplasm of Low Malignant Potential: Evolving Terminology and Concepts",
abstract = "Purpose: The most controversial aspect of the new WHO 2004/ISUP classification system is the creation of the PUNLMP diagnostic category. We discuss PUNLMP tumors and the WHO 2004/ISUP classification system with an emphasis on tumor morphology and heterogeneity, recurrence and progression rates, tumor genetics, interobserver variability and the usefulness of biomarkers and molecular diagnostic techniques for grading bladder tumors. Materials and Methods: A literature search using PubMed was performed. All relevant literature concerning PUNLMP and the WHO 2004/ISUP grading system for urothelial neoplasms was reviewed. Results: The new WHO 2004/ISUP classification reflects work in progress. Low malignant potential terminology may not reflect the true biological behavior of these tumors. Additionally, interobserver variability in making a diagnosis of PUNLMP is high despite detailed histological criteria. Urine cytopathology in the context of the WHO 2004/ISUP classification does not appear to effectively discriminate PUNLMP from low grade carcinoma. Conclusions: For practical purposes patients with PUNLMP should be treated similarly to patients with low grade, noninvasive urothelial carcinoma. It is our hope that recent advances in the molecular grading of these tumors may eventually supplant traditional morphological classification, allowing a more precise and objective assessment of the biological potential of these tumors.",
keywords = "bladder, bladder neoplasms, carcinoma, classification, papillary, urothelium",
author = "Jones, {Timothy D.} and Liang Cheng",
year = "2006",
month = "6",
doi = "10.1016/S0022-5347(06)00267-9",
language = "English",
volume = "175",
pages = "1995--2003",
journal = "Journal of Urology",
issn = "0022-5347",
publisher = "Elsevier Inc.",
number = "6",

}

TY - JOUR

T1 - Papillary Urothelial Neoplasm of Low Malignant Potential

T2 - Evolving Terminology and Concepts

AU - Jones, Timothy D.

AU - Cheng, Liang

PY - 2006/6

Y1 - 2006/6

N2 - Purpose: The most controversial aspect of the new WHO 2004/ISUP classification system is the creation of the PUNLMP diagnostic category. We discuss PUNLMP tumors and the WHO 2004/ISUP classification system with an emphasis on tumor morphology and heterogeneity, recurrence and progression rates, tumor genetics, interobserver variability and the usefulness of biomarkers and molecular diagnostic techniques for grading bladder tumors. Materials and Methods: A literature search using PubMed was performed. All relevant literature concerning PUNLMP and the WHO 2004/ISUP grading system for urothelial neoplasms was reviewed. Results: The new WHO 2004/ISUP classification reflects work in progress. Low malignant potential terminology may not reflect the true biological behavior of these tumors. Additionally, interobserver variability in making a diagnosis of PUNLMP is high despite detailed histological criteria. Urine cytopathology in the context of the WHO 2004/ISUP classification does not appear to effectively discriminate PUNLMP from low grade carcinoma. Conclusions: For practical purposes patients with PUNLMP should be treated similarly to patients with low grade, noninvasive urothelial carcinoma. It is our hope that recent advances in the molecular grading of these tumors may eventually supplant traditional morphological classification, allowing a more precise and objective assessment of the biological potential of these tumors.

AB - Purpose: The most controversial aspect of the new WHO 2004/ISUP classification system is the creation of the PUNLMP diagnostic category. We discuss PUNLMP tumors and the WHO 2004/ISUP classification system with an emphasis on tumor morphology and heterogeneity, recurrence and progression rates, tumor genetics, interobserver variability and the usefulness of biomarkers and molecular diagnostic techniques for grading bladder tumors. Materials and Methods: A literature search using PubMed was performed. All relevant literature concerning PUNLMP and the WHO 2004/ISUP grading system for urothelial neoplasms was reviewed. Results: The new WHO 2004/ISUP classification reflects work in progress. Low malignant potential terminology may not reflect the true biological behavior of these tumors. Additionally, interobserver variability in making a diagnosis of PUNLMP is high despite detailed histological criteria. Urine cytopathology in the context of the WHO 2004/ISUP classification does not appear to effectively discriminate PUNLMP from low grade carcinoma. Conclusions: For practical purposes patients with PUNLMP should be treated similarly to patients with low grade, noninvasive urothelial carcinoma. It is our hope that recent advances in the molecular grading of these tumors may eventually supplant traditional morphological classification, allowing a more precise and objective assessment of the biological potential of these tumors.

KW - bladder

KW - bladder neoplasms

KW - carcinoma

KW - classification

KW - papillary

KW - urothelium

UR - http://www.scopus.com/inward/record.url?scp=33646378397&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33646378397&partnerID=8YFLogxK

U2 - 10.1016/S0022-5347(06)00267-9

DO - 10.1016/S0022-5347(06)00267-9

M3 - Article

VL - 175

SP - 1995

EP - 2003

JO - Journal of Urology

JF - Journal of Urology

SN - 0022-5347

IS - 6

ER -